Overview:

The study involved two major activities in estimating the current market size of the fill finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Research Methodologies Followed for This Study:

Primary Research:

Extensive primary research was conducted after acquiring basic knowledge about the global fill finish manufacturing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from biopharma & pharma companies, clinical laboratories, and academic & research institutes; and purchase managers in healthcare provider organizations) and supply-side (such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners, among others) across four major regions-North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively.

Secondary Research:

The secondary sources referred for this research study include publications from government sources, such as the World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), International Society for Pharmaceutical Engineering (ISPE), Parenteral Drug Association (PDA), BioPharm International, and the National Center for Biotechnology Information (NCBI). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; and trade, business, and professional associations, among others.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609

Expected Revenue Gains:

The global fill-finish manufacturing market size is projected to grow from USD 7.5 billion in 2020 to USD 12.1 billion by 2025, at a CAGR of 10.0% during the forecast period.

Major Growth Boosting Factors:

The major factors driving the growth of this market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms. However, the high costs associated with isolators or restricted access barrier systems (RABS) is a factor expected to limit the growth of this market to a certain extent

By product, the consumables segment accounted for the largest share of the fill finish manufacturing market.

Based on the product, the market is segmented into consumables and instruments. The consumables segment is bifurcated further into prefilled syringes, vials, cartridges and other consumables such as ampoules, bottles, and IV bags. The instruments segment is further divided into machines and systems. Machines are further segmented by type into automated machines and semi-automated & manual machines. Systems, on the other hand, are further segmented into standalone systems and integrated systems.

The consumables segment dominated the market in 2019 and is expected to be the fastest-growing segment during the forecast period. The large share and high growth of this segment can primarily be attributed to the rising demand for prefilled syringes, wide applications of vials in lyophilization, and the growing use of disposable packaging for biologics.

By end user, the contract manufacturing organizations segment is expected to witness the highest growth in the fill finish manufacturing market during the forecast period.

The contract manufacturing organizations segment is expected to show the highest growth in the forecast period due to increasing outsourcing of fill-finish manufacturing processes from small-sized biopharmaceutical companies and the growing number of new entrants in the biologics manufacturing market.

Europe accounted for the largest market share during the forecast period.

The fill finish manufacturing market is divided into five major regions-Europe, North America, Asia Pacific, LATAM, and MEA. Europe accounted for the largest share of the global market, closely followed by North America. Factors such as the emergence of the biosimilar market due to the patent expiry of key biologic products, rising incidence of chronic disorders, and the increasing focus of major players on increasing their presence in this region are driving the growth of the fill-finish manufacturing industry in Europe.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609

Key Players:

The Asia Pacific region is expected to witness the highest CAGR during the forecast period, mainly due to overall growth in the biopharmaceutical industry. The growth of the APAC biopharmaceutical market is attributed to factors, such as increasing investments by CMOs & key biopharmaceutical players, increasing government support, developments in R&D infrastructure, and expertise & academic excellence in the APAC region.